Computer-aided design of nanocapsules for therapeutic delivery

References

• Feng , S.S. and Chien , S. 2003 . Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases . Chem. Eng. Sci. , 58 ( 18 ) : 4087 – 4114 .
   Web of Science ®Google Scholar
• Park , J.W. 2002 . Liposome-based drug delivery in breast cancer treatment . Breast Cancer Res. , 4 ( 3 ) : 93 – 97 .
   Google Scholar
• Sinha , R. , Kim , G.J. , Nie , S.M. and Shin , D.M. 2006 . Nanotechnology in cancer therapeutics: Bioconjugated nanoparticles for drug delivery . Mol. Cancer Ther. , 5 ( 8 ) : 1909 – 1917 .
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas , L. and Blanchette , J.O. 2004 . Nanoparticle and targeted systems for cancer therapy . Adv. Drug Deliv. Rev. , 56 ( 11 ) : 1649 – 1659 .
   PubMed Web of Science ®Google Scholar
• Devi , G.R. 2006 . siRNA-based approaches in cancer therapy . Cancer Gene Ther. , 13 ( 9 ) : 819 – 829 .
   PubMed Web of Science ®Google Scholar
• Halder , J. , Kamat , A.A. , Landen , C.N. , Han , L.Y. , Lutgendorf , S.K. , Lin , Y.G. , Merritt , W.M. , Jennings , N.B. , Chavez-Reyes , A. Coleman , R.L. 2006 . Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy . Clin. Cancer Res. , 12 ( 16 ) : 4916 – 4924 .
   PubMed Web of Science ®Google Scholar
• Takeshita , F. and Ochiya , T. 2006 . Therapeutic potential of RNA interference against cancer . Cancer Sci. , 97 ( 8 ) : 689 – 696 .
   PubMed Web of Science ®Google Scholar
• Kim , T.H. , Jin , H. , Kim , H.W. , Cho , M.H. and Cho , C.S. 2006 . Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells . Mol. Cancer Ther. , 5 ( 7 ) : 1723 – 1732 .
   PubMed Web of Science ®Google Scholar
• Seymour , L.W. 2006 . The future of gene therapy in the UK . Trends Biotechnol. , 24 ( 8 ) : 347 – 349 .
   Google Scholar
• Suh , J. , Wirtz , D. and Hanes , J. 2003 . Efficient active transport of gene nanocarriers to the cell nucleus . Proc. Natl. Acad. Sci. USA , 100 ( 7 ) : 3878 – 3882 .
   PubMed Web of Science ®Google Scholar
• Drummond , D.C. , Meyer , O. , Hong , K.L. , Kirpotin , D.B. and Papahadjopoulos , D. 1999 . Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors . Pharmacol. Rev. , 51 ( 4 ) : 691 – 743 .
   PubMed Web of Science ®Google Scholar
• Nagayasu , A. , Uchiyama , K. and Kiwada , H. 1999 . The size of liposomes: A factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs . Adv. Drug Deliv. Rev. , 40 ( 1–2 ) : 75 – 87 .
   PubMed Web of Science ®Google Scholar
• Charrois , G.J.R. and Allen , T.M. 2004 . Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer . Biochim. Biophys. Acta Biomembr. , 1663 ( 1–2 ) : 167 – 177 .
   PubMed Web of Science ®Google Scholar
• Srinath , P. and Diwan , P.V. 1994 . Stealth liposomes – an overview . Indian J. Pharm. , 26 : 179 – 184 .
   Google Scholar
• Uziely , B. , Jeffers , S. , Isacson , R. , Kutsch , K. , Weitsao , D. , Yehoshua , Z. , Libson , E. , Muggia , F.M. and Gabizon , A. 1995 . Liposomal doxorubicin – activity and unique toxicities during 2 complementary phase-I studies . J. Clin. Oncol. , 13 ( 7 ) : 1777 – 1785 .
   PubMed Web of Science ®Google Scholar
• Siwak , D.R. , Tari , A.M. and Lopez-Berestein , G. 2002 . The potential of drug-carrying immunoliposomes as anticancer agents . Clin. Cancer Res. , 8 ( 4 ) : 955 – 956 .
   Google Scholar
• Huwyler , J. , Wu , D.F. and Pardridge , W.M. 1996 . Brain drug delivery of small molecules using immunoliposomes . Proc. Natl. Acad. Sci. USA , 93 ( 24 ) : 14164 – 14169 .
   PubMed Web of Science ®Google Scholar
• Forssen , E. and Willis , M. 1998 . Ligand-targeted liposomes . Adv. Drug Deliv. Rev. , 29 ( 3 ) : 249 – 271 .
   PubMed Web of Science ®Google Scholar
• Khan , A. , Shukla , Y. , Kalra , N. , Alam , M. , Ahmad , M.G. , Hakim , S.R. and Owais , M. 2007 . Potential of diallyl sulfide bearing pH-sensitive liposomes in chemoprevention against DMBA-induced skin papilloma . Mol. Med. , 13 ( 7–8 ) : 443 – 451 .
   Google Scholar
• Kale , A.A. and Torchillin , V.P. 2007 . Enhanced transfection of tumor cells in vivo using ‘Smart’ pH-sensitive TAT-modified pegylated liposomes . J. Drug Target. , 15 ( 7–8 ) : 538 – 545 .
   PubMed Web of Science ®Google Scholar
• Drummond , D.C. , Zignani , M. and Leroux , J.C. 2000 . Current status of pH-sensitive liposomes in drug delivery . Prog. Lipid Res. , 39 ( 5 ) : 409 – 460 .
   PubMed Web of Science ®Google Scholar
• Wells , J. , Sen , A. and Hui , S.W. 2003 . Localized delivery to CT-26 tumors in mice using thermosensitive liposomes . Int. J. Pharm. , 261 ( 1–2 ) : 105 – 114 .
   PubMed Web of Science ®Google Scholar
• Dromi , S. , Frenkel , V. , Luk , A. , Traughber , B. , Angstadt , M. , Bur , M. , Poff , J. , Xie , J.W. , Libutti , S.K. Li , K.C.P. 2007 . Pulsed-high intensity focused ultrasound and low temperature sensitive liposomes for enhanced targeted drug delivery and antitumor effect . Clin. Cancer Res. , 13 ( 9 ) : 2722 – 2727 .
   PubMed Web of Science ®Google Scholar
• Shum , P. , Kim , J.M. and Thompson , D.H. 2001 . Phototriggering of liposomal drug delivery systems . Adv. Drug Deliv. Rev. , 53 ( 3 ) : 273 – 284 .
   PubMed Web of Science ®Google Scholar
• Meers , P. 2001 . Enzyme-activated targeting of liposomes . Adv. Drug Deliv. Rev. , 53 ( 3 ) : 04490
   Google Scholar
• Harashima , H. and Kiwada , H. 1999 . The pharmacokinetics of liposomes in tumor targeting . Adv. Drug Deliv. Rev. , 40 : 39 – 61 .
   PubMed Web of Science ®Google Scholar
• Kanjickal , D.G. and Lopina , S.T. 2004 . Modeling of drug release from polymeric delivery systems – a review . Crit. Rev. Ther. Drug Carrier Syst. , 21 ( 5 ) : 345 – 386 .
   Google Scholar
• Cooney , D.O. 1972 . Effect of geometry dissolution of pharmaceutical tablets and other solids – surface detachment kinetics controlling . AIChE J. , 18 ( 2 ) : 446 – 449 .
   Google Scholar
• Peppas , N.A. 1985 . Analysis of Fickian and non-Fickian drug release from polymers . Pharm. Acta Helvetiae , 60 ( 4 ) : 110 – 111 .
   PubMedGoogle Scholar
• Lee , P.I. 1980 . Diffusional release of a solute from a polymeric matrix – approximate analytical solutions . J. Membr. Sci. , 7 ( 3 ) : 255 – 275 .
   Google Scholar
• Göpferich , A. 1997 . Bioerodible implants with programmable drug release . J. Control. Release , 44 ( 2–3 ) : 271 – 281 .
   Google Scholar
• Ortoleva , P. 2005 . Nanoparticle dynamics: A multiscale analysis of the Liouville equation . J. Phys. Chem. B , 109 ( 45 ) : 21258 – 21266 .
   Google Scholar
• Miao , Y. and Ortoleva , P. 2006 . All-atom multiscaling and new ensembles for dynamical nanoparticles . J. Chem. Phys. , 125 ( 4 ) : 044901
   Google Scholar
• Miao , Y. and Ortoleva , P. 2006 . Viral structural transitions: An all-atom multiscale theory . J. Chem. Phys. , 125 ( 21 ) : 214901
   Google Scholar
• Shreif , Z. and Ortoleva , P. 2008 . Curvilinear all-atom multiscale (CAM) theory of macromolecular dynamics . J. Stat. Phys. , 130 ( 4 ) : 669 – 685 .
   Google Scholar
• Yang , J. , Lee , H. , Hyung , W. , Park , S.B. and Haam , S. 2006 . Magnetic PECA nanoparticles as drug carriers for targeted delivery: Synthesis and release characteristics . J. Microencapsul. , 23 ( 2 ) : 203 – 212 .
   PubMed Web of Science ®Google Scholar
• Pankavich , S. , Shreif , Z. and Ortoleva , P. 2008 . Multiscaling for classical nanosystems: Derivation of Smoluchowski & Fokker–Planck equations . Physica A , 387 ( 16–17 ) : 4053 – 4069 .
   Google Scholar
• Batist , G. , Ramakrishnan , G. , Rao , C.S. , Chandrasekharan , A. , Gutheil , J. , Guthrie , T. , Shah , P. , Khojasteh , A. , Nair , M.K. Hoelzer , K. 2001 . Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicentre trial of metastatic breast cancer . J. Clin. Oncol. , 19 ( 5 ) : 1444 – 1454 .
   PubMed Web of Science ®Google Scholar
• Allen , T.M. , Mumbengegwi , D.R. and Charrois , G.J.R. 2005 . Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates . Clin. Cancer Res. , 11 ( 9 ) : 3567 – 3573 .
   Google Scholar